The significance of reactive oxygen species in the formation of calcium oxalate stones and the protective effects of antioxidants on the kidneys
- PMID: 40469275
- PMCID: PMC12133935
- DOI: 10.3389/fimmu.2025.1540075
The significance of reactive oxygen species in the formation of calcium oxalate stones and the protective effects of antioxidants on the kidneys
Abstract
Exposure of renal tubular epithelial cells (RTCs) to kidney stones or calcium oxide crystals triggers the production of reactive oxygen species (ROS), leading to oxidative stress. This oxidative milieu incites cellular injury and elicits an inflammatory cascade within the RTCs. Notably, the cellular membranes of the compromised cells facilitate the adherence and subsequent retention of crystals, which is instrumental in the pathogenesis of kidney stones. The pathways of ROS production are diverse, involving numerous signaling cascades. Recent researchers' endeavors have elucidated that selective antioxidants can attenuate intracellular ROS concentrations by modulating these intricate signaling cascades. This reduction in ROS levels has been empirically demonstrated to significantly curtail the accumulation of calcium oxalate crystals within renal tissues in animal models, heralding a novel therapeutic paradigm for the amelioration of nephrolithiasis. In this review, we endeavor to elucidate the contributory role of ROS in kidney stone and explore the protective mechanisms by which certain antioxidants safeguard renal function.
Keywords: antioxidants; kidney stones; oxidative stress; reactive oxygen species; renal.
Copyright © 2025 Ying, Chen, Hao and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Reactive oxygen species as the molecular modulators of calcium oxalate kidney stone formation: evidence from clinical and experimental investigations.J Urol. 2013 Mar;189(3):803-11. doi: 10.1016/j.juro.2012.05.078. Epub 2012 Sep 25. J Urol. 2013. PMID: 23022011 Free PMC article. Review.
-
PPARγ agonist alleviates calcium oxalate nephrolithiasis by regulating mitochondrial dynamics in renal tubular epithelial cell.PLoS One. 2024 Sep 26;19(9):e0310947. doi: 10.1371/journal.pone.0310947. eCollection 2024. PLoS One. 2024. PMID: 39325731 Free PMC article.
-
Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.Biomed Pharmacother. 2020 Jan;121:109649. doi: 10.1016/j.biopha.2019.109649. Epub 2019 Nov 13. Biomed Pharmacother. 2020. PMID: 31733571
-
Identification of Resolvin D1 and Protectin D1 as Potential Therapeutic Agents for Treating Kidney Stones.Oxid Med Cell Longev. 2022 Feb 24;2022:4345037. doi: 10.1155/2022/4345037. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35251472 Free PMC article.
-
Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.Urol Res. 2005 Nov;33(5):349-57. doi: 10.1007/s00240-005-0492-4. Epub 2005 Nov 15. Urol Res. 2005. PMID: 16292585 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical